Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Protein Expression and Purification

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.pep.2010.04.008PMID 20399865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Conserved Hydrophobic Tetrad near the C Terminus of the Secretory Na+-K+-2Cl- Cotransporter (NKCC1) Is Required for Its Correct Intracellular Processing*

  2009cited by this paper
• Mapping the structure of an integral membrane protein under semi-denaturing conditions by laser-induced oxidative labeling and mass spectrometry.

  2009cited by this paper
• Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041*

  2009cited by this paper
• Post-translational modifications of connexin26 revealed by mass spectrometry.

  2009cited by this paper
• Disrupted plasma membrane localization and loss of function reveal regions of human equilibrative nucleoside transporter 1 involved in structural integrity and activity.

  2009cited by this paper
• Analysis of integral membrane proteins by heat gel‐embedment combined with improved in‐gel digestions

  2009cited by this paper
• Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

  2009cited by this paper
• Identification of phosphorylation-dependent binding partners of aquaporin-2 using protein mass spectrometry.

  2009cited by this paper
• Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome.

  2009cited by this paper
• Gel-based mass spectrometric analysis of a strongly hydrophobic GABAA-receptor subunit containing four transmembrane domains

  2009cited by this paper
• Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions

  2009cited by this paper
• The C-terminal region of serotonin transporter is important for its trafficking and glycosylation.

  2009cited by this paper
• Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.

  2008cited by this paper
• A shotgun proteomic method for the identification of membrane-embedded proteins and peptides.

  2008cited by this paper
• Physiological and Pharmacological Roles of Nucleoside Transporter Proteins

  2008cited by this paper
• Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins

  2008cited by this paper
• Physiology of nucleoside transporters: back to the future. . . .

  2008cited by this paper
• Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting.

  2008cited by this paper
• Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.

  2008cited by this paper
• Analysis of Glucose Transporter Topology and Structural Dynamics*

  2008cited by this paper
• Overcoming the challenges of membrane protein crystallography

  2008cited by this paper
• Proteomic characterization of membrane protein topology.

  2008cited by this paper
• Structure and mechanics of membrane proteins.

  2008cited by this paper
• Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2

  2007cited by this paper
• Structural biology of membrane proteins.

  2007cited by this paper
• The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

  2007cited by this paper
• Comprehensive Examination of Charged Intramembrane Residues in a Nucleoside Transporter*

  2006cited by this paper
• Rat organic anion transporting protein 1A1 (Oatp1a1): purification and phosphopeptide assignment.

  2006cited by this paper
• Cell‐free expression as an emerging technique for the large scale production of integral membrane protein

  2006cited by this paper
• Purification and mass spectrometric analysis of the delta opioid receptor.

  2005cited by this paper
• The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase Cϵ in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1

  2004cited by this paper
• The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma

  2004cited by this paper
• Hiding behind Hydrophobicity

  2004cited by this paper
• Biochemical Characterization of β2-Adrenergic Receptor Dimers and Oligomers

  2003cited by this paper
• Tandem affinity purification of protein complexes from mammalian cells.

  2002cited by this paper
• PKC regulation of the human equilibrative nucleoside transporter, hENT1

  2002cited by this paper
• Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes.

  2002cited by this paper
• The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.

  2002cited by this paper
• Combined in-gel tryptic digestion and CNBr cleavage for the generation of peptide maps of an integral membrane protein with MALDI-TOF mass spectrometry.

  2002cited by this paper
• Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation.

  2001cited by this paper
• Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins.

  2001cited by this paper
• Kinetic and Pharmacological Properties of Cloned Human Equilibrative Nucleoside Transporters, ENT1 and ENT2, Stably Expressed in Nucleoside Transporter-deficient PK15 Cells

  2000cited by this paper
• Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

  1999cited by this paper
• Demonstration of Equilibrative Nucleoside Transporters (hENT1 and hENT2) in Nuclear Envelopes of Cultured Human Choriocarcinoma (BeWo) Cells by Functional Reconstitution in Proteoliposomes*

  1998cited by this paper
• Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.

  1997cited by this paper
• Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol.

  1996cited by this paper
• Functional expression of the nitrobenzylthioinosine-sensitive nucleoside transporter of human choriocarcinoma (BeWo) cells in isolated oocytes of Xenopus laevis.

  1994cited by this paper
• Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters.

  1993cited by this paper
• Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.

  1992cited by this paper
• Chromatographic characterization of nitrobenzylthioinosine binding proteins in band 4.5 of human erythrocytes: purification of a 40 kDa truncated nucleoside transporter.

  1990cited by this paper
• Purification of the human erythrocyte nucleoside transporter by immunoaffinity chromatography.

  1988cited by this paper
• Radiation inactivation of the human erythrocyte nucleoside and glucose transporters.

  1986cited by this paper
• Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum

  1982cited by this paper

• Porcine Epidemic Diarrhea Virus Is Inhibited by GS-441524 During an In Vitro Infection

  2025cites this paper
• 6 Adenosinergic System in the Mesenteric Vessels

  2018influential citation
• Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.

  2017cites this paper
• Functional characterization of human equilibrative nucleoside transporter 1

  2016cites this paper
• N-linked glycosylation of N48 is required for equilibrative nucleoside transporter 1 (ENT1) function

  2016cites this paper
• N-linked glycosylation of N 48 is required for equilibrative nucleoside transporter 1 ( ENT 1 ) function

  2016cites this paper
• Interactions of AMPAR-Adenosine Receptor-Equilibrative Nucleoside Transporter in the Hippocampus: Implication for Stroke

  2015cites this paper
• Adenosinergic System in the Mesenteric Vessels

  2012cites this paper
• Human Equilibrative Nucleoside Transporter Subtype 1: Structure-Function Analysis Using Cysteine Mutagenesis and Thiol Modifying Techniques

  2012cites this paper
• Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.

  2012cites this paper
• Analysis of recombinant tagged equilibrative nucleoside transporter 1 (ENT1) expressed in E. coli.

  2011influential citation
• REGULATION OF ADENOSINE TRANSPORTER AND AMPA RECEPTOR SUBUNIT LOCALIZATION BY PROTEIN KINASE CK2 IN RAT HIPPOCAMPUS

  2011cites this paper
• The life cycle of human equilibrative nucleoside transporter 1: from ER export to degradation.

  2011cites this paper